ArticleScience progress
EnzyDiff: Sequence-based classification of mutation-induced enzyme activity direction using latent diffusion denoising.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectivePrediction of mutation-induced enzyme activity changes is important for protein engineering, drug response analysis, and precision medicine. Existing methods often depend on structural information or complex external pipelines, limiting reproducibility and practical use.MethodsWe developed EnzyDiff, a lightweight diffusion-based framework that encodes mutation-induced activity perturbations from enzyme sequences before and after mutation, together with mutation identity and position. The model was evaluated on the P450 deep mutational scanning dataset using five-fold cross-validation, with additional analyses of robustness, representation visualization, and case-based occlusion sensitivity. After preprocessing, 3,289 labeled mutation entries were retained, including 240 Increased samples and 3,049 Decreased samples.ResultsIn five-fold cross-validation, EnzyDiff achieved an accuracy of 0.933, F1-score of 0.497, AUROC of 0.803, and PR-AUC of 0.495 on the P450 dataset. It remained stable under reversed mutation settings, showed clear class separation in learned representations, and highlighted mutation-relevant positions in interpretability analyses. However, the moderate F1-score also indicates that minority-class prediction remains challenging under strong class imbalance.ConclusionsEnzyDiff is a lightweight, reproducible, and interpretable framework for enzyme activity direction classification. It offers a practical sequence-based solution for functional mutation assessment and downstream biological analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.